MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 10-28-2024
Inari Medical Total Non Current Liabilities 2011-2025 | NARI
Annual Total Non Current Liabilities Inari Medical
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 74.8 M | 64.2 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 74.8 M | 64.2 M | 69.5 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
19.1 M | - | - | $ 17.2 B |  USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 20.95 | -0.1 % | $ 2.99 B | USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 9.28 | -0.32 % | $ 666 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.54 | 2.91 % | $ 123 M | USA |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 95.79 | -0.24 % | $ 141 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.35 B | $ 303.53 | -0.15 % | $ 8.56 B | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 28.33 | -0.6 % | $ 240 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 48.37 | 0.74 % | $ 7.21 K | USA |
 |
Abbott Laboratories
ABT
|
25.7 B | $ 124.66 | -0.14 % | $ 217 B | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.25 | -4.41 % | $ 121 M |  France |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
12 M | $ 14.81 | 1.3 % | $ 1.17 B | Israel |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.17 | -4.88 % | $ 18.9 M | USA |
 |
IRadimed Corporation
IRMD
|
4.76 M | $ 97.65 | 0.21 % | $ 1.24 B | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
LivaNova PLC
LIVN
|
516 M | $ 62.29 | -0.93 % | $ 3.38 B |  Britain |
|
LENSAR
LNSR
|
3.44 M | $ 11.93 | -0.21 % | $ 137 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
184 M | $ 158.32 | -0.03 % | $ 11.9 B | USA |
 |
NanoVibronix
NAOV
|
18 | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
196 M | $ 0.81 | -1.31 % | $ 83.2 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 13.56 | -3.28 % | $ 366 M | USA |
 |
FONAR Corporation
FONR
|
36.4 M | $ 14.46 | 0.07 % | $ 94.8 M | USA |
 |
AxoGen
AXGN
|
1.61 M | $ 33.15 | 1.07 % | $ 1.47 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 41.41 | 1.57 % | $ 1.28 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
84.7 M | $ 17.7 | 2.08 % | $ 408 M | USA |
 |
Globus Medical
GMED
|
18.2 M | $ 88.34 | -0.08 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 12.58 | -0.32 % | $ 969 M | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |